Please enable Javascript to use all features and improve your user experience.
GPTS 2024
Programme
Posters
People
Search
EN
Back
Poster
Poster Walk and Get Together 3
Disease models, drug development
Appointment
Date:
13/03/2024
Time:
17:00
–
18:30
Location / Stream:
Poster Self-Study 3
Vorsitz
Bernhard Rauch
Oldenburg / DE
Anke Fender
Essen / DE
Programme
Poster Self-Study
P027
Heart-directed overexpression of the PP2A regulatory subunit PR72 resulted in premature ischemic contracture but preserved contractility during reperfusion
Lars Schmidt (Münster / DE)
Disease models, drug development
Poster Self-Study
P028
Recombinant CTRPs exert anti-apoptotic and anti-hypertrophic effects in cardiomyocytes
Constanze Schanbacher (Würzburg / DE)
Disease models, drug development
Poster Self-Study
P029
cGMP-dependent PDE2 activation as a potential antiarrhythmic therapy strategy in heart failure
Rebecca Firneburg (Dresden / DE)
Disease models, drug development
Poster Self-Study
P030
Pharmacological reversal of behavioural and microglial aberrancies in a model of high trait anxiety
Simone B. Sartori (Innsbruck / AT)
Disease models, drug development
Poster Self-Study
P031
Proteome analysis of mouse retinas carrying pathogenic Cav1.4 L-type calcium channel variants
Matthias Ganglberger (Innsbruck / AT)
Disease models, drug development
Poster Self-Study
P032
Do the isoforms of the human farnesyltransferase have unique functions and response to respective inhibitors?
Anna Hagemann (Witten / DE)
Disease models, drug development
Poster Self-Study
P033
SMAD4 maintains the Fluid Shear Stress set point to protect against Arterial-Venous Malformations
Roxana Ola (Mannheim / DE)
Disease models, drug development
Poster Self-Study
P034
cellasys #8: An assay for monitoring metabolism and morphology of organ-models in real-time
Joachim Wiest (Kronburg / DE)
Disease models, drug development
Poster Self-Study
P035
Neuronal processing of hypercapnia-induced anxiety in a model of high trait anxiety
Nino Kobakhidze (Innsbruck / AT)
Disease models, drug development
Poster Self-Study
P036
Investigating the active centrum of the humane farnesyltransferase β-subunit for a better druggability
Tobias Wellbrock (Witten / DE)
Disease models, drug development
Poster Self-Study
P037
"From Drugs to Drugs": History of Neosalvarsan as chemical starting lead for numerous pharmacological classes with diverse pharmacological activities and clinical indications in the 20th century
Hubert Heuer (Schwabenheim / DE)
Disease models, drug development
Poster Self-Study
P038
Dissecting the
in vivo
role of X-linked lncRNA loci with conserved sex- and allele-specific epigenetic signatures
Tim Hasenbein (Munich / DE)
Disease models, drug development
Poster Self-Study
P039
Transneuronal delivery of designer-cytokine enables functional recovery after severe chronic spinal cord injury in mice
Marco Leibinger (Cologne / DE)
Disease models, drug development
Poster Self-Study
P040
Reduced CRMP2 activity by p35/CDK5 compromises nerve regeneration in diabetes
Philipp Gobrecht (Cologne / DE)
Disease models, drug development
Poster Self-Study
P041
The lncRNA landscape of cardiac resident macrophages and identification of
Schlafenlnc
as a regulator of macrophage migratory function
Anne Dueck (Munich / DE)
Disease models, drug development
Poster Self-Study
P042
Receptor of Hyaluronan-Mediated Motility (RHAMM) confers protection after acute cardiac ischemia
Angelika Pastuschka (Düsseldorf / DE)
Disease models, drug development
Poster Self-Study
P043
Novel selenium compounds acting as potent inhibitors of ferroptosis
Melanie Merkel (Marburg / DE)
Disease models, drug development
Poster Self-Study
P044
Sympathetic denervation of the pineal gland in heart disease
Karin Ziegler (Munich / DE)
Disease models, drug development
Poster Self-Study
P045
The purely thermodynamic anti-prionic mode of action for the treatment of neurodegenerative diseases.
Dieter Willbold (Jülich / DE)
Disease models, drug development
Poster Self-Study
P046
A Novel Chemotype of Cyclin Dependent Kinase Inhibitors Potent for Neuroblastoma Cells
Erik Gandalipov (Berlin / DE)
Disease models, drug development
Poster Self-Study
P047
Anti-inflammatory and Anti-oxidative Effects of STW 42 and Root Extract of
Althaea officinalis
L. on endothelial cells, fibroblasts and macrophages
in vitro
Olaf Kelber (Darmstadt / DE)
Disease models, drug development
Poster Self-Study
P048
Elucidating missing X factors to understand sex bias in cardiovascular diseas
Sarah Hoelzl (Munich / DE)
Disease models, drug development
Poster Self-Study
P049
Effects of STW 3-VI (St. John's wort) on the paracrine signaling between neurons and microglia under pro-inflammatory conditions
in vitro
Olaf Kelber (Darmstadt / DE)
Disease models, drug development
Poster Self-Study
P050
Assessment of immunogenicity in mice and cross-species activity of an engineered complement regulator
Christoph Schmidt (Ulm / DE)
Disease models, drug development
Poster Self-Study
P051
Diabetes impairs β-adrenergic signal transduction in the remote myocardium during the reparative phase after ischemia/reperfusion injury
Florian Funk (Düsseldorf / DE)
Disease models, drug development
Poster Self-Study
P052
Identification of key lncRNAs in cardiac resident macrophages using pooled CRISPR screens
Niklas Petzold (Munich / DE)
Disease models, drug development
Poster Self-Study
P053
A long non-coding RNA that regulates MHCII expression in cardiac macrophages
Lara Althaus (Munich / DE)
Disease models, drug development
Poster Self-Study
P054
A high-throughput radioligand receptor binding assay for the evaluation of therapeutic candidates for the treatment of nerve agent poisoning
Fabian Springer (Munich / DE)
Disease models, drug development
Poster Self-Study
P055
Screening for cardiomyocyte and fibroblast specific compound activity in a novel induced pluripotent stem cell high-content-screening platform.
Guobin Bao (Goettingen / DE)
Gabriela L. Santos (Goettingen / DE)
Branimir Berečić (Goettingen / DE)
Disease models, drug development
Poster Self-Study
P056
Force-generating skeletal muscle organoids recapitulate normal and perturbed human muscle development
Malte Rinn (Goettingen / DE)
Disease models, drug development
Poster Self-Study
P057
OLEAF4VALUE: Protective effects of olive (
Olea europaea
L.) leave extracts in the model organism Caenorhabditis elegans
Wim Wätjen (Halle (Saale) / DE)
Disease models, drug development
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy